Skip to main content

Table 4 Multivariate-Cox-regression-analysis for disease-free survival and overall-survival of breast-cancer patients

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

  

DFS

  

OS

 
 

HR

95% CI

p

HR

95% CI

P

Tumor stage

0,807

0,435–1,496

0,496

1,393

0,658–2,948

0,386

Lymph node status

6,737

2,607–17,409

0,000

5,99

1,920–18,688

0,002

ER/PR status

0,405

0,196–0,837

0,015

   

M3H67 reactivity

4,355

1,218–15,572

0,024

7,693

2,597–22,786

0,000

57B reactivity

1,328

0,229–7,713

0,752

0,71

0,120–4,216

0,706

  1. Abbreviations: DFS Disease free survival; OS Overall survival; HR Hazard ratio; CI Confidence interval.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us